Literature DB >> 10508250

Shared structural motifs in TCR of glycopeptide-recognizing T cell hybridomas.

T Jensen1, P Hansen, A Faurskov Nielsen, M Meldal, S Komba, O Werdelin.   

Abstract

The TCR structure of T cell hybridomas recognizing a tumor glycan-defined epitope has been studied using reverse transcriptase-PCR and gene sequencing. The hybridomas had been raised against a glycopeptide, T72(Tn), consisting of the mouse hemoglobin-derived decapeptide Hb(67 - 76), O-glycoslated in position 72 with alpha-D-GalNAc. The glycan-specific hybridomas varied widely in their use of Valpha genes although Valpha4 was predominant, being present in one third of them. The Vbeta gene usage was more restricted and dominated by Vbeta1 and Vbeta15. There was no correlation between Valpha and Vbeta usage and antigen fine specificity of the hybridomas. The overall amino acid composition of the complementarity-determining region (CDR) 3 of the hybridomas was dominated by small polar residues such as Gly, Asn, Ser, Glu and Ala, amino acids reported in the literature to be frequent in glycan-recognizing proteins. Furthermore, the CDR3 of most hybridomas also contained an aromatic residue with preference for Tyr. A few of the hybridomas raised against the T72(Tn) glycopeptide were peptide specific, i. e. they responded to the unglycosylated peptide only. The amino acid usage of their CDR3 regions was not radically different from that of the glycopeptide specific hybridomas. They also preferentially used Valpha4. However, Vbeta4 and Vbeta8 were the dominating beta chains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508250     DOI: 10.1002/(SICI)1521-4141(199909)29:09<2759::AID-IMMU2759>3.0.CO;2-4

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Processing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells.

Authors:  Ole Werdelin; Morten Meldal; Teis Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

2.  Characterization of T cell hybridomas raised against a glycopeptide containing the tumor-associated T antigen, (betaGal (1-3) alphaGalNAc-O/Ser).

Authors:  Monika Gad; Ole Werdelin; Morten Meldal; Shiro Komba; Teis Jensen
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

Review 3.  T Cell Receptor Profiling in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Amanda Posgai; Howard R Seay; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2017-10-11       Impact factor: 4.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.